Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round Thursday evening:

Caterpillar (CAT): “Even though Caterpillar’s probably not going to have a good quarter, I don’t mind owning it.”

Facebook (FB): “They can earn $3.15 per share in 2017, which can take the stock to $100.”

Alcoa (AA): “We’re waiting for the company to get into more titanium and aircraft businesses -- waiting for the RTI acquisition to close.”

Juno Therapeutics (JUNO): “High-risk, speculative biotech; but it’s not bad as long as you understand the risk.”

Cypress Semiconductor (CY): “The stock’s been disappointing despite some great acquisitions. I want you to stick with it, though.”

Kite Pharma (KITE): “Another speculative play, but I like BlueBird Bio (BLUE) instead.”

Citigroup (C): “Citigroup is a buy.”

Rexx Energy (REXX): “We want to be in oil stocks, which are undervalued, not natural gas.”

Insys Therapeutics (INSY): “It’s real and it’s good. This is a good company.”

To read a full recap of "Mad Money" on CNBC, click here.

If you liked this article you might like

FedEx Makes A Comeback: Cramer's Top Takeaways

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

Crazy Weak U.S. Dollar Will Make These 10 Companies Huge Winners

Caterpillar May Be Ready to Take a Breather

Cramer: FedEx Will Win Big With Global E-Commerce Growth 'On Steroids'